John W Childs - Net Worth and Insider Trading
John W Childs Net Worth
The estimated net worth of John W Childs is at least $137 Million dollars as of 2023-03-24. John W Childs is the Director of Biohaven Ltd and owns about 5,696,251 shares of Biohaven Ltd (BHVN) stock worth over $79 Million. John W Childs is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 2,560,801 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $36 Million. John W Childs is also the Director, 10% Owner of Mattress Firm Holding Corp and owns about 345,038 shares of Mattress Firm Holding Corp (MFRM) stock worth over $22 Million. Details can be seen in John W Childs's Latest Holdings Summary section.
Transaction Summary of John W Childs
John W Childs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John W Childs owns 3 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , Mattress Firm Holding Corp (MFRM) , and Biohaven Ltd (BHVN) .
Click here to see the complete history of John W Childs’s form 4 insider trades.
Insider Ownership Summary of John W Childs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2017-05-03 | director & 10 percent owner |
| MFRM | Mattress Firm Holding Corp | 2016-09-14 | director & 10 percent owner |
| BHVN | Biohaven Ltd | 2022-10-03 | director |
John W Childs Latest Holdings Summary
John W Childs currently owns a total of 3 stocks. Among these stocks, John W Childs owns 5,696,251 shares of Biohaven Ltd (BHVN) as of October 25, 2022, with a value of $79 Million and a weighting of 57.47%. John W Childs owns 2,560,801 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 10, 2021, with a value of $36 Million and a weighting of 26.37%. John W Childs also owns 345,038 shares of Mattress Firm Holding Corp (MFRM) as of February 3, 2016, with a value of $22 Million and a weighting of 16.16%.
Latest Holdings of John W Childs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd | 2022-10-25 | 5,696,251 | 13.80 | 78,579,783 |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-11-10 | 2,560,801 | 14.08 | 36,056,078 |
| MFRM | Mattress Firm Holding Corp | 2016-02-03 | 345,038 | 64.02 | 22,089,333 |
Holding Weightings of John W Childs
John W Childs Form 4 Trading Tracker
According to the SEC Form 4 filings, John W Childs has made a total of 2 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 3,900,000 shares on October 25, 2022, which cost John W Childs around $41 Million.
According to the SEC Form 4 filings, John W Childs has made a total of 9 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 8 buys and 1 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 5,000 shares on November 10, 2021, which cost John W Childs around $614,350.
According to the SEC Form 4 filings, John W Childs has made a total of 0 transactions in Mattress Firm Holding Corp (MFRM) over the past 5 years. The most-recent trade in Mattress Firm Holding Corp is the acquisition of 559,440 shares on February 3, 2016, which cost John W Childs around $20 Million.
Insider Trading History of John W Childs
- 1
John W Childs Trading Performance
GuruFocus tracks the stock performance after each of John W Childs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John W Childs is 24.81%. GuruFocus also compares John W Childs's trading performance to market benchmark return within the same time period. The performance of stocks bought by John W Childs within 3 months outperforms 11 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John W Childs's insider trading performs compared to the benchmark.
Performance of John W Childs
Average Relative Return
71.68%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 7.71 | 24.81 | 29.63 | 71.68 | 61.62 | 42.33 |
| Relative Return to S&P 500(%) | 4.3 | 18.87 | 17.84 | 50.34 | 49.45 | 33.71 |
John W Childs Ownership Network
Ownership Network List of John W Childs
Ownership Network Relation of John W Childs
John W Childs Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
John W Childs is the director & 10 percent owner of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include Officer Matthew Buten , VP & Chief Accounting Officer George C. Clark , and Chief Medical Officer Elyse Stock .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
Over the past 18 months, John W Childs made 1 insider transaction in Biohaven Pharmaceutical Holding Co Ltd (BHVN) with a net purchase of 5,000. Other recent insider transactions involving Biohaven Pharmaceutical Holding Co Ltd (BHVN) include a net sale of 15,490 shares made by George C. Clark , a net sale of 62,265 shares made by Declan Doogan , and a net purchase of 38,000 shares made by Gregory Bailey .
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 153,613 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 43,000 shares were bought by its insiders, resulting in a net sale of 110,613 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
NYSE:BHVN Insider Transactions
John W Childs Mailing Address
Above is the net worth, insider trading, and ownership report for John W Childs. You might contact John W Childs via mailing address: 111 Huntington Avenue, Suite 2900, Boston Ma 02199.
